Seronegative fibrosing cholestatic hepatitis С after liver retransplantation for unresectable neuroendocrine tumor liver metastases

We present an uncommon case of liver graft dysfunction caused by seronegative hepatitis C-related fibrosing cholestatic hepatitis after cadaver liver transplantation for unresectable liver metastases of neuroendocrine small intestine cancer followed by living relation donor liver fragment retranspla...

Full description

Bibliographic Details
Main Authors: S. E. Voskanyan, V. E. Syutkin, M. V. Shabalin, A. I. Artemyev, I. Yu. Kolyshev, A. N. Bashkov, A. M. Borbat, K. K. Gubarev, M. V. Popov, A. P. Maltseva
Format: Article
Language:English
Published: N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department 2020-12-01
Series:Трансплантология (Москва)
Subjects:
Online Access:https://www.jtransplantologiya.ru/jour/article/view/537
_version_ 1797696849442766848
author S. E. Voskanyan
V. E. Syutkin
M. V. Shabalin
A. I. Artemyev
I. Yu. Kolyshev
A. N. Bashkov
A. M. Borbat
K. K. Gubarev
M. V. Popov
A. P. Maltseva
author_facet S. E. Voskanyan
V. E. Syutkin
M. V. Shabalin
A. I. Artemyev
I. Yu. Kolyshev
A. N. Bashkov
A. M. Borbat
K. K. Gubarev
M. V. Popov
A. P. Maltseva
author_sort S. E. Voskanyan
collection DOAJ
description We present an uncommon case of liver graft dysfunction caused by seronegative hepatitis C-related fibrosing cholestatic hepatitis after cadaver liver transplantation for unresectable liver metastases of neuroendocrine small intestine cancer followed by living relation donor liver fragment retransplantation for primary graft nonfunction. Early postoperative period was complicated by hepatic artery thrombosis, cerebral hemorrhage, acute cellular rejection, bilateral polysegmental pneumonia, bleeding into neck soft tissues, severe surgical site infection, and sepsis. Anticoagulant therapy, as well as the absence of Hepatitis C Virus antibodies made difficult early diagnostics of fibrosing cholestatic hepatitis. A present-day antiviral therapy produced a complete clinical and virological response. At control examination performed at 240 days after surgery, there were neither signs of cancer progression no graft dysfunction. Liver transplantation in that case was an example of radical and effective treatment method for unresectable liver metastases of neuroendocrine small intestine cancer. Timely diagnosis and proper treatment of fibrosing cholestatic hepatitis made it possible to save the liver graft and patient's life.
first_indexed 2024-03-12T03:32:05Z
format Article
id doaj.art-ae911eb66c924b8d89f713e408381401
institution Directory Open Access Journal
issn 2074-0506
2542-0909
language English
last_indexed 2024-03-12T03:32:05Z
publishDate 2020-12-01
publisher N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department
record_format Article
series Трансплантология (Москва)
spelling doaj.art-ae911eb66c924b8d89f713e4083814012023-09-03T13:24:37ZengN.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare DepartmentТрансплантология (Москва)2074-05062542-09092020-12-0112431933110.23873/2074-0506-2020-12-4-319-331463Seronegative fibrosing cholestatic hepatitis С after liver retransplantation for unresectable neuroendocrine tumor liver metastasesS. E. Voskanyan0V. E. Syutkin1M. V. Shabalin2A. I. Artemyev3I. Yu. Kolyshev4A. N. Bashkov5A. M. Borbat6K. K. Gubarev7M. V. Popov8A. P. Maltseva9ФГБУ ГНЦ ФМБЦ им. А.И. Бурназяна ФМБА РоссииФГБУ ГНЦ ФМБЦ им. А.И. Бурназяна ФМБА России; ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского ДЗМ»ФГБУ ГНЦ ФМБЦ им. А.И. Бурназяна ФМБА РоссииФГБУ ГНЦ ФМБЦ им. А.И. Бурназяна ФМБА РоссииФГБУ ГНЦ ФМБЦ им. А.И. Бурназяна ФМБА РоссииФГБУ ГНЦ ФМБЦ им. А.И. Бурназяна ФМБА РоссииФГБУ ГНЦ ФМБЦ им. А.И. Бурназяна ФМБА РоссииФГБУ ГНЦ ФМБЦ им. А.И. Бурназяна ФМБА РоссииФГБУ ГНЦ ФМБЦ им. А.И. Бурназяна ФМБА РоссииФГБУ ГНЦ ФМБЦ им. А.И. Бурназяна ФМБА РоссииWe present an uncommon case of liver graft dysfunction caused by seronegative hepatitis C-related fibrosing cholestatic hepatitis after cadaver liver transplantation for unresectable liver metastases of neuroendocrine small intestine cancer followed by living relation donor liver fragment retransplantation for primary graft nonfunction. Early postoperative period was complicated by hepatic artery thrombosis, cerebral hemorrhage, acute cellular rejection, bilateral polysegmental pneumonia, bleeding into neck soft tissues, severe surgical site infection, and sepsis. Anticoagulant therapy, as well as the absence of Hepatitis C Virus antibodies made difficult early diagnostics of fibrosing cholestatic hepatitis. A present-day antiviral therapy produced a complete clinical and virological response. At control examination performed at 240 days after surgery, there were neither signs of cancer progression no graft dysfunction. Liver transplantation in that case was an example of radical and effective treatment method for unresectable liver metastases of neuroendocrine small intestine cancer. Timely diagnosis and proper treatment of fibrosing cholestatic hepatitis made it possible to save the liver graft and patient's life.https://www.jtransplantologiya.ru/jour/article/view/537нейроэндокринный рак тонкой кишкиметастазыфиброзирующий холестатический гепатит ссеронегативный гепатит свозвратный гепатит саллотрансплантат печенидисфункциятрансплантация печениосложнения
spellingShingle S. E. Voskanyan
V. E. Syutkin
M. V. Shabalin
A. I. Artemyev
I. Yu. Kolyshev
A. N. Bashkov
A. M. Borbat
K. K. Gubarev
M. V. Popov
A. P. Maltseva
Seronegative fibrosing cholestatic hepatitis С after liver retransplantation for unresectable neuroendocrine tumor liver metastases
Трансплантология (Москва)
нейроэндокринный рак тонкой кишки
метастазы
фиброзирующий холестатический гепатит с
серонегативный гепатит с
возвратный гепатит с
аллотрансплантат печени
дисфункция
трансплантация печени
осложнения
title Seronegative fibrosing cholestatic hepatitis С after liver retransplantation for unresectable neuroendocrine tumor liver metastases
title_full Seronegative fibrosing cholestatic hepatitis С after liver retransplantation for unresectable neuroendocrine tumor liver metastases
title_fullStr Seronegative fibrosing cholestatic hepatitis С after liver retransplantation for unresectable neuroendocrine tumor liver metastases
title_full_unstemmed Seronegative fibrosing cholestatic hepatitis С after liver retransplantation for unresectable neuroendocrine tumor liver metastases
title_short Seronegative fibrosing cholestatic hepatitis С after liver retransplantation for unresectable neuroendocrine tumor liver metastases
title_sort seronegative fibrosing cholestatic hepatitis с after liver retransplantation for unresectable neuroendocrine tumor liver metastases
topic нейроэндокринный рак тонкой кишки
метастазы
фиброзирующий холестатический гепатит с
серонегативный гепатит с
возвратный гепатит с
аллотрансплантат печени
дисфункция
трансплантация печени
осложнения
url https://www.jtransplantologiya.ru/jour/article/view/537
work_keys_str_mv AT sevoskanyan seronegativefibrosingcholestatichepatitissafterliverretransplantationforunresectableneuroendocrinetumorlivermetastases
AT vesyutkin seronegativefibrosingcholestatichepatitissafterliverretransplantationforunresectableneuroendocrinetumorlivermetastases
AT mvshabalin seronegativefibrosingcholestatichepatitissafterliverretransplantationforunresectableneuroendocrinetumorlivermetastases
AT aiartemyev seronegativefibrosingcholestatichepatitissafterliverretransplantationforunresectableneuroendocrinetumorlivermetastases
AT iyukolyshev seronegativefibrosingcholestatichepatitissafterliverretransplantationforunresectableneuroendocrinetumorlivermetastases
AT anbashkov seronegativefibrosingcholestatichepatitissafterliverretransplantationforunresectableneuroendocrinetumorlivermetastases
AT amborbat seronegativefibrosingcholestatichepatitissafterliverretransplantationforunresectableneuroendocrinetumorlivermetastases
AT kkgubarev seronegativefibrosingcholestatichepatitissafterliverretransplantationforunresectableneuroendocrinetumorlivermetastases
AT mvpopov seronegativefibrosingcholestatichepatitissafterliverretransplantationforunresectableneuroendocrinetumorlivermetastases
AT apmaltseva seronegativefibrosingcholestatichepatitissafterliverretransplantationforunresectableneuroendocrinetumorlivermetastases